Investors didn't show much interest in one Prime Medicine way or another today. It hasn't moved too much today but is slightly down, it lost -0.36% since yesterday.
Currently PRME isn't at a clear support/resistance line that seems tradable. Prime Medicine hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. PRME might find some support at the 21.11 level, buyers might push the price back up from here. But it's not very clear what will happen.
Prime Medicine has an overall positive view by the analysts. The current Analysts Sentiment Score is 177.40. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2024-04-22 Chardan Capital started covering Prime Medicine with a rating of Buy and added a price target of $17.00. TD Cowen initiated a rating of Buy on 2024-04-08. On 2024-04-02 Wedbush started covering Prime Medicine with a rating of Outperform and provided a price target of $12.00. Guggenheim dropped their price target by -16.67% to $20.00 on 2024-03-05. Stifel Nicolaus downgraded from Buy to Hold on 2024-01-16 and they lowered their price target by -50% to $9.00 from a previous target of $18.00. Citigroup initiated a rating of Neutral on 2023-12-08 and provided a price target of $10.00. JPMorgan Chase & Co. provided a price target decease of -3.7% to $26.00 from $27.00 on 2023-11-07. BMO Capital Markets initiated a rating of Outperform on 2023-10-09 and provided a price target of $19.00. On 2023-09-06 Jonestrading started covering Prime Medicine with a rating of Buy and they set their price target at $20.00.Morgan Stanley announced a lowering of their price target to $19.00 from $21.00 on 2023-08-14.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| PRME | 177.40 | 251.52 | -29.93 | 182.41 | -49.2 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| PRME | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| PRME | 0 | %0 | 0 | 0 | 0 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| PRME |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
